MedPath

海南绿岛制药有限公司

Ownership
-
Established
1992-10-28
Employees
-
Market Cap
-
Website
www.hngip.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:10

Drug Approvals

Carvedilol Tablets

Product Name
卡维地洛片
Approval Number
国药准字H20083899
Approval Date
Jun 8, 2023
NMPA

Carvedilol Tablets

Product Name
卡维地洛片
Approval Number
国药准字H20093407
Approval Date
Mar 17, 2023
NMPA

Carvedilol Tablets

Product Name
卡维地洛片
Approval Number
国药准字H20083898
Approval Date
Mar 17, 2023
NMPA

Terazosin Hydrochloride

Product Name
盐酸特拉唑嗪
Approval Number
国药准字H10950154
Approval Date
Jun 23, 2020
NMPA

Terazosin Hydrochloride Tablets

Product Name
盐酸特拉唑嗪片
Approval Number
国药准字H10950155
Approval Date
Jun 17, 2020
NMPA

Compound Octavitamins and Methyltestosterone Capsules

Product Name
复方八维甲睾酮胶囊
Approval Number
国药准字H46020528
Approval Date
Jun 17, 2020
NMPA

Compound Bismuth Aluminate Tablets

Product Name
复方铝酸铋片
Approval Number
国药准字H46020484
Approval Date
May 18, 2020
NMPA

Cefalexin Granules

Product Name
头孢氨苄颗粒
Approval Number
国药准字H46020379
Approval Date
Oct 16, 2002
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H46020378
Approval Date
Oct 16, 2002
NMPA

Cefradine for Suspension

Product Name
头孢拉定干混悬剂
Approval Number
国药准字H46020104
Approval Date
Jul 10, 2002
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath